1.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics
2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185
countries. CA: a cancer journal for clinicians. 2018;68(6):394-424. doi:10.3322/caac.21492
2.
AD W. Advanced gastric cancer: Current treatment landscape and future perspectives.%A
Digklia A. World journal of gastroenterology. 2016;22(8):2403-14.
3.
Harada K, Mizrak Kaya D, Shimodaira Y, Ajani JA. Global chemotherapy development for
gastric cancer. Gastric cancer : official journal of the International Gastric Cancer
Association and the Japanese Gastric Cancer Association. 2017;20(Suppl 1):92-101.
doi:10.1007/s10120-016-0655-8
4.
Cardoso R, Coburn NG, Seevaratnam R, et al. A systematic review of patient surveillance
after curative gastrectomy for gastric cancer: a brief review. Gastric cancer : official
journal of the International Gastric Cancer Association and the Japanese Gastric Cancer
Association. 2012;15(1):164-7. doi:10.1007/s10120-012-0142-9
5.
Laks S, Meyers MO, Kim HJ. Surveillance for Gastric Cancer. The Surgical clinics of
North America. 2017;97(2):317-31. doi:10.1016/j.suc.2016.11.007
6.
Harada K, Lopez A, Shanbhag N, Badgwell B, Baba H, Ajani J. Recent advances in the
management of gastric adenocarcinoma patients. F1000Research. 2018;7. doi:10.12688/f1000research.15133.1
7.
You H, Yang J, Liu Q, et al. The impact of the lymph node density on overall survival
in patients with Wilms' tumor: a SEER analysis. Cancer management and research. 2018;10:671-7.
doi:10.2147/cmar.s163514
8.
Yang J, Chen S, Li Y, et al. Incidence rate and risk factors for suicide death in
patients with skin malignant melanoma: a Surveillance, Epidemiology, and End Results
analysis. Melanoma research. 2018. doi:10.1097/cmr.0000000000000559
9.
Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for
cancer prognosis. Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 2008;26(8):1364-70. doi:10.1200/jco.2007.12.9791
10.
Roberto M, Botticelli A, Strigari L, et al. Prognosis of elderly gastric cancer patients
after surgery: a nomogram to predict survival. Medical oncology (Northwood, London,
England). 2018;35(7):111. doi:10.1007/s12032-018-1166-8
11.
Muneoka Y, Akazawa K, Ishikawa T, et al. Nomogram for 5-year relapse-free survival
of a patient with advanced gastric cancer after surgery. International journal of
surgery (London, England). 2016;35:153-9. doi:10.1016/j.ijsu.2016.09.080
12.
Zhou Z, Zhang H, Xu Z, Li W, Dang C, Song Y. Nomogram predicted survival of patients
with adenocarcinoma of esophagogastric junction. World journal of surgical oncology.
2015;13:197. doi:10.1186/s12957-015-0613-7
13.
Kim Y, Spolverato G, Ejaz A, et al. A nomogram to predict overall survival and disease-free
survival after curative resection of gastric adenocarcinoma. Annals of surgical oncology.
2015;22(6):1828-35. doi:10.1245/s10434-014-4230-4
14.
Song KY, Park YG, Jeon HM, Park CH. A nomogram for predicting individual survival
of patients with gastric cancer who underwent radical surgery with extended lymph
node dissection. Gastric cancer : official journal of the International Gastric Cancer
Association and the Japanese Gastric Cancer Association. 2014;17(2):287-93. doi:10.1007/s10120-013-0270-x
15.
Dikken JL, Baser RE, Gonen M, et al. Conditional probability of survival nomogram
for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer. Annals
of surgical oncology. 2013;20(5):1623-30. doi:10.1245/s10434-012-2723-6
16.
Zumsteg ZS, Cook-Wiens G, Yoshida E, et al. Incidence of Oropharyngeal Cancer Among
Elderly Patients in the United States. JAMA oncology. 2016;2(12):1617-23. doi:10.1001/jamaoncol.2016.1804
17.
Ye FG, Xia C, Ma D, Lin PY, Hu X, Shao ZM. Nomogram for predicting preoperative lymph
node involvement in patients with invasive micropapillary carcinoma of breast: a SEER
population-based study. BMC cancer. 2018;18(1):1085. doi:10.1186/s12885-018-4982-5
18.
Alba AC, Agoritsas T, Walsh M, et al. Discrimination and Calibration of Clinical Prediction
Models: Users' Guides to the Medical Literature. Jama. 2017;318(14):1377-84. doi:10.1001/jama.2017.12126
19.
Fitzgerald M, Saville BR, Lewis RJ. Decision curve analysis. Jama. 2015;313(4):409-10.
doi:10.1001/jama.2015.37
20.
Wang PL, Xiao FT, Gong BC, Liu FN, Xu HM. A Nomogram for Predicting Overall Survival
of Gastric Cancer Patients with Insufficient Lymph Nodes Examined. Journal of gastrointestinal
surgery : official journal of the Society for Surgery of the Alimentary Tract. 2017;21(6):947-56.
doi:10.1007/s11605-017-3401-6
21.
Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics,
2016. CA: a cancer journal for clinicians. 2016;66(4):271-89. doi:10.3322/caac.21349
22.
DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics,
2014. CA: a cancer journal for clinicians. 2014;64(4):252-71. doi:10.3322/caac.21235
23.
Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics,
2012. CA: a cancer journal for clinicians. 2012;62(4):220-41. doi:10.3322/caac.21149
24.
Kunz PL, Gubens M, Fisher GA, Ford JM, Lichtensztajn DY, Clarke CA. Long-term survivors
of gastric cancer: a California population-based study. Journal of clinical oncology
: official journal of the American Society of Clinical Oncology. 2012;30(28):3507-15.
doi:10.1200/jco.2011.35.8028
25.
Zhong Q, Chen QY, Li P, et al. Prediction of Conditional Probability of Survival After
Surgery for Gastric Cancer: A Study Based on Eastern and Western Large Data Sets.
Surgery. 2018;163(6):1307-16. doi:10.1016/j.surg.2018.02.011
26.
Shang-Guan XC, Chen QY, Li P, et al. Preoperative lymph node size is helpful to predict
the prognosis of patients with stage III gastric cancer after radical resection. Surgical
oncology. 2018;27(1):54-60. doi:10.1016/j.suronc.2017.11.009
27.
Jiang S, Zhao R, Li Y, et al. Prognosis and nomogram for predicting postoperative
survival of duodenal adenocarcinoma: A retrospective study in China and the SEER database.
Scientific reports. 2018;8(1):7940. doi:10.1038/s41598-018-26145-6
28.
Wu Q, Wang WJ, Huang YQ, Fang SY, Guan YJ. Nomograms for estimating survival in patients
with liver-only colorectal metastases: A retrospective study. International journal
of surgery (London, England). 2018;60:1-8. doi:10.1016/j.ijsu.2018.10.032
29.
Zhou W, Huang C, Yuan N. Prognostic nomograms based on log odds of positive lymph
nodes for patients with renal cell carcinoma: A retrospective cohort study. International
journal of surgery (London, England). 2018;60:28-40. doi:10.1016/j.ijsu.2018.10.038
30.
Wu S, Chen JN, Zhang QW, et al. A New Metastatic Lymph Node Classification-based Survival
Predicting Model in Patients With Small Bowel Adenocarcinoma: A Derivation and Validation
Study. EBioMedicine. 2018;32:134-41. doi:10.1016/j.ebiom.2018.05.022
31.
Tang X, Zhou X, Li Y, et al. A Novel Nomogram and Risk Classification System Predicting
the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal
Cancer: A SEER-Based Study. Annals of surgical oncology. 2018. doi:10.1245/s10434-018-6929-0
32.
Sun Y, Wang J, Li Y, et al. Nomograms to predict survival rates for esophageal cancer
patients with malignant behaviors based on ICD-0-3. Future oncology (London, England).
2018. doi:10.2217/fon-2018-0493
33.
Dong F, Shen Y, Gao F, et al. Nomograms to Predict Individual Prognosis of Patients
with Primary Small Cell Carcinoma of the Bladder. Journal of Cancer. 2018;9(7):1152-64.
doi:10.7150/jca.23344